- Home
- WM vs BDX Comparison
WM vs BDX Comparison
Compare WM & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WM
- BDX
- Stock Information
- Founded
- WM 1987
- BDX 1897
- Country
- WM United States
- BDX United States
- Employees
- WM N/A
- BDX N/A
- Industry
- WM Environmental Services
- BDX Medical/Dental Instruments
- Sector
- WM Utilities
- BDX Health Care
- Exchange
- WM Nasdaq
- BDX Nasdaq
- Market Cap
- WM 83.6B
- BDX 68.0B
- IPO Year
- WM 1988
- BDX 1962
- Fundamental
- Price
- WM $217.90
- BDX $225.23
- Analyst Decision
- WM Buy
- BDX Strong Buy
- Analyst Count
- WM 21
- BDX 7
- Target Price
- WM $226.37
- BDX $283.00
- AVG Volume (30 Days)
- WM 1.5M
- BDX 1.6M
- Earning Date
- WM 10-28-2024
- BDX 11-07-2024
- Dividend Yield
- WM 1.38%
- BDX 1.69%
- EPS Growth
- WM 15.95
- BDX N/A
- EPS
- WM 6.55
- BDX 4.84
- Revenue
- WM $21,387,000,000.00
- BDX $19,828,000,000.00
- Revenue This Year
- WM $9.72
- BDX $5.13
- Revenue Next Year
- WM $10.65
- BDX $8.06
- P/E Ratio
- WM $33.28
- BDX $45.01
- Revenue Growth
- WM 6.17
- BDX 4.11
- 52 Week Low
- WM $168.73
- BDX $218.75
- 52 Week High
- WM $226.84
- BDX $249.89
- Technical
- Relative Strength Index (RSI)
- WM 52.72
- BDX 36.45
- Support Level
- WM $212.48
- BDX $226.25
- Resistance Level
- WM $226.84
- BDX $236.00
- Average True Range (ATR)
- WM 3.94
- BDX 5.48
- MACD
- WM 0.28
- BDX -1.08
- Stochastic Oscillator
- WM 39.10
- BDX 8.34
About WM Waste Management Inc.
WM ranks as the largest integrated provider of traditional solid waste services in the United States, operating 263 active landfills and about 332 transfer stations. The company serves residential, commercial, and industrial end markets and is also a leading recycler in North America.
About BDX Becton Dickinson and Company
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures pre-filled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2023 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.